Global Autoimmune Disease Diagnosis Market, By Product and Service (Product Type and Services), Test (Routine Laboratory Tests, Inflammatory Markets, Autoantibodies and Immunologic Tests Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, and Others Tests and Others), Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Scleroderma, Systemic Autoimmune Disease and Localized Autoimmune Disease), End User (Hospitals, Clinical Labs) – Industry Trends and Forecast to 2031.
Autoimmune Disease Diagnosis Market Analysis and Size
The autoimmune disease diagnosis market is vital for identifying and managing conditions such as rheumatoid arthritis, lupus, and multiple sclerosis. Utilized in clinical settings, these diagnostics enable early detection, precise disease monitoring, and personalized treatment strategies, improving patient outcomes and quality of life in autoimmune disease management.
Data Bridge Market Research analyses that the global autoimmune disease diagnosis market, which was USD 5.28 billion in 2023, is expected to reach USD 9.88 billion by 2031, and is expected to undergo a CAGR of 8.15% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Autoimmune Disease Diagnosis Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable to 2016-2021) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Product and Service (Product Type and Services), Test (Routine Laboratory Tests, Inflammatory Markets, Autoantibodies and Immunologic Tests Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), C-reactive Protein (CRP), Urinalysis, and Others Tests and Others), Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Scleroderma, Systemic Autoimmune Disease and Localized Autoimmune Disease), End User (Hospitals, Clinical Labs) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
Market Players Covered |
Siemens AG (Germany), Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher (U.S.), Grifols, S.A. (Spain), Bio-Rad Laboratories Inc. (U.S.), ProtaGene (Germany), HYCOR Biomedical (U.S.), Nova (U.S.), Trinity Biotech (Ireland), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Quest (U.S.), Hemagen Diagnostics Inc. (U.S.), Crescendo Biologics Ltd (U.S.), AESKU GROUP GmbH (Germany), SQI Diagnostics (Canada), Seramun Diagnostica GmbH (Germany) |
Market Opportunities |
|
Market Definition
Autoimmune disease diagnosis involves a comprehensive approach, combining medical history, physical examination, laboratory tests, and imaging studies. Common diagnostic tools include blood tests to detect autoantibodies and inflammation markers, imaging techniques such as MRI or ultrasound, and biopsy for tissue analysis, aiding in accurate identification and management of autoimmune conditions.
Global Autoimmune Disease Diagnosis Market Dynamics
Drivers
- Increasing Prevalence in Aging Population Need Accurate Diagnostic Methods
The increasing prevalence of autoimmune diseases among the aging population necessitates more accurate and tailored diagnostic methods. This drives the market by creating demand for innovative solutions that address the unique challenges of diagnosing autoimmune conditions in older adults, spurring the development of advanced diagnostic technologies.
- Government Initiatives for Early Diagnosis and Treatment
Government initiatives aimed at enhancing healthcare infrastructure and advocating for early diagnosis and treatment of autoimmune diseases stimulate market growth by increasing access to diagnostic services and treatment options. Such initiatives foster a conducive environment for the development and adoption of innovative diagnostic technologies, driving market expansion.
Opportunities
- Focus on Point-of-Care Testing for Convenient Diagnosis
Point-of-care testing's rising demand presents a significant market opportunity, as it meets the need for quick, convenient diagnosis in various healthcare settings. Offering rapid results and easy implementation, these solutions enhance patient care, streamline workflow for providers, and drive market growth by catering to evolving healthcare demands efficiently.
- Rising Healthcare Expenditure for Efficient Diagnostic Tools
Rising healthcare expenditure in emerging economies presents a significant opportunity for the autoimmune disease diagnosis market. With increased funding, healthcare systems can invest in advanced diagnostic technologies, driving market growth by expanding access to accurate and efficient diagnostic tools for autoimmune diseases in these regions.
Restraints/Challenges
- Ethical and Legal Considerations in Genetic Testing
Ethical and legal concerns regarding genetic testing and personalized medicine create uncertainty, deterring both individuals and healthcare providers from embracing these diagnostic approaches. This hesitation limits market growth for autoimmune disease diagnosis due to compromised patient privacy, inadequate consent processes, and the potential misuse of genetic information.
- High Cost of Diagnostic Tests Limits Accessibility
The high cost of advanced diagnostic tests for autoimmune diseases restricts accessibility in resource-constrained settings, hampering market growth. This financial barrier hinders widespread adoption, limiting the market's reach and preventing many individuals from undergoing crucial diagnostic procedures, contributing to a substantial gap in autoimmune disease diagnosis and management.
This global autoimmune disease diagnosis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global autoimmune disease diagnosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In August 2022, KSL Beutner Laboratories (Beutner) launched a blood test designed to detect an antigen associated with mucous membrane pemphigoid (MMP), a distressing autoimmune blistering disease known to cause lesions in the oral cavity. This innovation promises improved diagnostic accuracy and early detection of MMP, enhancing patient care and management
- In May 2022, Thermofisher launched the Phadia 2500+ series of instruments in the U.S., catering to autoimmune testing needs. With its high throughput capabilities and reliability, this system serves both allergy diagnostics and autoimmune testing, offering healthcare professionals unparalleled efficiency and accuracy in diagnosing autoimmune conditions
- In January 2021, Thermo Fisher Scientific Inc. launched the Phadia 200, enhancing flexibility and automation in lab testing facilities across Europe. This advancement aids in detecting allergies and autoimmune diseases, offering improved diagnostic capabilities to healthcare professionals and patients identical
- In September 2020, SQI Diagnostics Inc., a Canadian firm specializing in organ transplants, autoimmune diseases, and serological testing, expanded its quick diagnostic testing range. This extension enhances the company's ability to provide rapid and accurate diagnostic solutions, catering to the diverse needs of healthcare providers and patients worldwide
Global Autoimmune Disease Diagnosis Market Scope
The global autoimmune disease diagnosis market is segmented on the basis of product and service, disease, end user and test. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Service
- Product Type
- Consumables
- Assay Kits
- Instruments
- Services
Test
- Routine Laboratory Tests
- Inflammatory Markets
- Autoantibodies and Immunologic Tests
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count (CBC)
- C-reactive Protein (CRP)
- Urinalysis
- Others
Disease
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Thyroiditis
- Scleroderma
- Systemic Autoimmune Disease
- Localized Autoimmune Disease
End User
- Hospitals
- Clinical Labs
Global Autoimmune Disease Diagnosis Market Regional Analysis/Insights
The global autoimmune disease diagnosis market is analysed and market size insights and trends are provided by country, product and service, disease, end use and test as referenced above.
The countries covered in the global autoimmune disease diagnosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the autoimmune disease diagnosis market in terms of market share and revenue, poised to maintain its supremacy throughout the forecast period. This dominance is attributed to the escalating incidence of chronic diseases within the region, driving demand for advanced diagnostic solutions and fostering market growth.
The Asia-Pacific region exhibits the fastest-growing compound annual growth rate (CAGR) in the forecast period, driven by a growing geriatric population. This demographic trend correlates with a rise in chronic disease incidences across the region, emphasizing the pressing need for improved healthcare infrastructure and disease management strategies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global autoimmune disease diagnosis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global autoimmune disease diagnosis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global autoimmune disease diagnosis market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Autoimmune Disease Diagnosis Market Share Analysis
The global autoimmune disease diagnosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global autoimmune disease diagnosis market.
Some of the major players operating in the global autoimmune disease diagnosis market are:
- Siemens AG (Germany)
- Abbott (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Danaher (U.S.)
- Grifols, S.A. (Spain)
- Bio-Rad Laboratories Inc. (U.S.)
- ProtaGene (Germany)
- HYCOR Biomedical (U.S.)
- Nova (U.S.)
- Trinity Biotech (Ireland)
- EUROIMMUN Medizinische Labordiagnostika AG(Germany)
- Quest (U.S.)
- Hemagen Diagnostics Inc. (U.S.)
- Crescendo Biologics Ltd (U.S.)
- AESKU GROUP GmbH (Germany)
- SQI Diagnostics (Canada)
- Seramun Diagnostica GmbH (Germany)
SKU-